A new Journal of Sexual Medicine study has examined the effects of partner responses on women with female sexual interest/arousal disorder (FSIAD). Positive, supportive partner responses are associated with better couple adjustment than negative responses, researchers report. While women may experience FSIAD differently, the most typical symptoms include feeling little sexual desire and having trouble […]
Sexual abuse at any age may predict hypersexuality in both men and women, researchers report in the Journal of Sexual Medicine. However, the association is stronger in men who have experienced abuse as children and adolescents/adults. Hypersexual individuals experience sexual urges and behaviors that are difficult to control, causing great distress. Sexual thoughts and actions […]
Taking flibanserin with alcohol does not appear to add to adverse events, according to a recent alcohol-interaction study. Approved in the United States and Canada, flibanserin is an oral medication for the treatment of acquired generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Women with HSDD have a persistent, distressing lack of or decrease […]
The International Society for Sexual Medicine (ISSM), along with the International Society for the Study of Women’s Sexual Health (ISSWSH) and nine other medical organizations, has endorsed the “Global Consensus Position Statement on the Use of Testosterone Therapy for Women.” The position statement provides guidelines for clinicians who consider prescribing testosterone therapy to female patients. […]
Earlier this month, the U.S. Food and Drug Administration (FDA) changed the safety labeling for Addyi (flibanserin), a medication used to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Women with this type of HSDD have little or no interest in sex, even though they have had a satisfying libido in the […]
Aromatase inhibitors (AIs) are associated with hypoactive sexual desire disorder (HSDD) and fecal incontinence in breast cancer survivors ten years after diagnosis, according to a recent Journal of Sexual Medicine study.